ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,204.95
0.33%
Dow Jones
39,256.24
0.51%
US Dollar vs MXN
16.90689
-0.07%
Brent Oil
83.705
0.17%
Bitcoin
61,374.12
0.31%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. USOTC
  6. Roche Holdings Ltd AG (QX) (RHHBY)

  7. Roche Holdings Ltd AG (QX) (RHHBY) Noticias

RHHBY

Roche (QX) (RHHBY)

Roche Holdings Ltd AG (QX)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:USOTC:RHHBY
FechaHoraFuenteTítuloSímboloCompañía
16/01/202400:49Dow Jones NewsRoche's Cancer Injection Tecentriq SC Gets European Commission ApprovalUSOTC:RHHBYRoche Holdings Ltd AG (QX)
10/01/202407:45InvestorsHub NewsWireGLP-1: Beyond Diabetes, a Blockbuster Horizon BeckonsUSOTC:RHHBYRoche Holdings Ltd AG (QX)
29/12/202316:07Dow Jones NewsLumiraDx Agrees to Sell Point-of-Care Tech Platform to RocheUSOTC:RHHBYRoche Holdings Ltd AG (QX)
19/12/202309:27Dow Jones NewsRoche's Xolair Granted FDA Priority ReviewUSOTC:RHHBYRoche Holdings Ltd AG (QX)
11/12/202309:31Dow Jones NewsPoseida Therapeutics Shares Climb on Positive Data for Blood Cancer TreatmentUSOTC:RHHBYRoche Holdings Ltd AG (QX)
08/12/202311:56Dow Jones NewsRoche Obtains Positive Data on Early-Stage Breast Cancer TreatmentUSOTC:RHHBYRoche Holdings Ltd AG (QX)
08/12/202311:38Dow Jones NewsRoche's Inavolisib Breast Cancer Drug Gets Positive ResultsUSOTC:RHHBYRoche Holdings Ltd AG (QX)
06/12/202304:14Dow Jones NewsMerck Shares Slump After Multiple Sclerosis Drug Fails in Late-Stage TrialsUSOTC:RHHBYRoche Holdings Ltd AG (QX)
05/12/202300:54Dow Jones NewsRoche's Inavolisib Breast Cancer Drug Shows Promise in Late-Stage StudyUSOTC:RHHBYRoche Holdings Ltd AG (QX)
04/12/202309:12Dow Jones NewsTrending: Roche to Buy Carmot Therapeutics in Deal Worth Up to $3.1 BillionUSOTC:RHHBYRoche Holdings Ltd AG (QX)
04/12/202305:34Dow Jones NewsRoche to Buy Carmot Therapeutics for Up to $3.1 Billion in Bet on Obesity Treatments -- UpdateUSOTC:RHHBYRoche Holdings Ltd AG (QX)
04/12/202304:55IH Market NewsAlaska Air Acquires Hawaiian Holdings, Spotify Cuts 1,500 Jobs, Uber’s S&P 500 Entry, and MoreUSOTC:RHHBYRoche Holdings Ltd AG (QX)
04/12/202300:47Dow Jones NewsRoche Strikes Deal to Buy Drug Developer Carmot Therapeutics for $2.7 BillionUSOTC:RHHBYRoche Holdings Ltd AG (QX)
21/11/202310:06Dow Jones NewsRoche's Genentech, Nvidia Team Up to Accelerate Drug Discovery With AIUSOTC:RHHBYRoche Holdings Ltd AG (QX)
07/11/202316:14Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesUSOTC:RHHBYRoche Holdings Ltd AG (QX)
31/10/202301:26Dow Jones NewsRoche Says Late-Stage Muscular Dystrophy Trial Didn't Meet Main GoalUSOTC:RHHBYRoche Holdings Ltd AG (QX)
27/10/202300:40Dow Jones NewsRoche Gets FDA Approval for Vabysmo as Retinal Vein Occlusion TreatmentUSOTC:RHHBYRoche Holdings Ltd AG (QX)
23/10/202314:41Dow Jones NewsTrending: Roche to Buy Telavant From Roivant and PfizerUSOTC:RHHBYRoche Holdings Ltd AG (QX)
23/10/202303:16Dow Jones NewsRoche to Buy Telavant From Roivant, Pfizer in Deal Worth Up to $7.25 Billion -- UpdateUSOTC:RHHBYRoche Holdings Ltd AG (QX)
23/10/202300:50Dow Jones NewsRoche to Buy Telavant From Roivant Sciences and Pfizer in $7.25 Billion DealUSOTC:RHHBYRoche Holdings Ltd AG (QX)
19/10/202304:55Dow Jones NewsRoche Shares Fall on Lower Sales Due to Currency HitUSOTC:RHHBYRoche Holdings Ltd AG (QX)
19/10/202300:48Dow Jones NewsRoche Backs Guidance After Sales FallUSOTC:RHHBYRoche Holdings Ltd AG (QX)
18/10/202301:14Dow Jones NewsRoche Lung Cancer Drug Reduced Risk of Recurrence, Death in Late-Stage TrialUSOTC:RHHBYRoche Holdings Ltd AG (QX)
18/10/202300:54Dow Jones NewsRoche's Elecsys IL-6 Test Approved for Diagnosis of Neonatal SepsisUSOTC:RHHBYRoche Holdings Ltd AG (QX)
29/09/202307:15Dow Jones NewsAbbVie: Phase 3 Venetoclax/Dexamethasone Study Falls Short in Multiple MyelomaUSOTC:RHHBYRoche Holdings Ltd AG (QX)
27/09/202306:59Dow Jones NewsIonis, Roche Set New Pact Targeting Alzheimer's, Huntington'sUSOTC:RHHBYRoche Holdings Ltd AG (QX)
20/09/202307:45InvestorsHub NewsWirePathways to Progress: How Orphan Drug Designation Sparks Biotech TransformationUSOTC:RHHBYRoche Holdings Ltd AG (QX)
06/09/202300:52Dow Jones NewsRoche's Blood Disorder Drug Crovalimab Takes Step Toward FDA ApprovalUSOTC:RHHBYRoche Holdings Ltd AG (QX)
01/09/202301:04Dow Jones NewsRoche Lung Cancer Drug Shows Promise in Phase 3 TrialUSOTC:RHHBYRoche Holdings Ltd AG (QX)
29/08/202304:51Dow Jones NewsRoche's Tecentriq Intravenous Cancer Therapy Gets UK ApprovalUSOTC:RHHBYRoche Holdings Ltd AG (QX)
 Showing the most relevant articles for your search:USOTC:RHHBY

Su Consulta Reciente

USOTC
ADDYY
Adidas (QX)
NYSE
BAC
Bank of America
NYSE
MRK
Merck
NASDAQ
AMZN
Amazon.com
NYSE
VZ
Verizon Communications
COIN
SOLUSD
Solana
USOTC
DTEGY
Deutsche Telekom (QX)
CCOM
US30
US 30
NASDAQ
NVDA
NVIDIA
NYSE
XOM
Exxon Mobil
NYSE
CVX
Chevron
PM
XAUUSD
Gold vs US Dollar
USI
USTECH100
US Tech 100
CCOM
OILBRENT
Brent Oil
AMEX
XLF
Financial Select Sector
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados